Company intelligence / Profile preview
Huaren Pharmaceutical
Qingdao, Shandong, Chinahuarenmedical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company has a broad commercial portfolio with over ninety-eight drug varieties across two hundred twelve specifications. Its main products—small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices—are all manufactured under GMP standards. All production lines have passed new GMP certification. Subsidiary Stellar Pharmaceutical holds a license as one of China’s designated manufacturers of Class II psychotropic APIs.
- Therapeutic areas
- PulmonologyMetabolic DisordersNephrologyOther
- Modalities
- Small moleculeBiologicDevice
- Industry
- Pharma
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Huaren Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huaren Pharmaceutical.